Results of histological examination of experimental diabetic retinopathy and its correction with metformin, aflibercept, L-arginine solution and cyticolin
DOI:
https://doi.org/10.12775/JEHS.2020.10.12.042Keywords
experimental diabetic retinopathy, streptozotocin diabetes, histological examination, correction, metformin, aflibercept, ; L-arginine, citicolineAbstract
The purpose of the study was to analyze the histological changes in the structures of the eyeball in experimental diabetic retinopathy and its correction with metformin, aflibercept, L-arginine solution and citicoline.
The obtained results indicate about the development of pathological changes in the retina against the background of the progression of experimental diabetes when streptozotocin is administered at dose 55 mg/kg of animal weight against the background of a high-fat diet. The development of simulated streptozotocin diabetes is accompanied by disturbance in the retina in the form of edematous shifts of fibers and swelling of the cells forming it, uneven distribution of cells of the ganglion layer and vacuolization of the cytoplasm some of them. The using of corrective drugs complex for metabolic disorders and angiopathy, which are characteristic of diabetes mellitus, affects on the retina condition. Under the influence of aflibercept, solution of L-arginine, citicoline, and metformin administration was established that edematous changes in its structural elements are significantly reduced, the number of vessels on the border with the retina visually increases, and the staining of the cells of the ganglion layer becomes more freshly.
References
Vorob'eva I. V., Repkina M. Ju. Prakticheskie rekomendacii o nabljudenii bol'nyh s diabeticheskoj retinopatiej // RMZh. Jendokrinologija. —2009. — T. 17, № 24. — S. 1591-1595.
Ametov A. S. Saharnyj diabet i serdechno-sosudistye zabolevanija [Jelektronnyj resurs] / A.S. Ametov, I.O. Kurochkin, A.A. Zubkov // RMZh. – 2014. – № 13. – S. 954–959. – Rezhim dostupa: http://www.rmj.ru/articles_9505.htm
Abbate M, Cravedi P, Iliev I, et al. Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives // Curr Diabetes Rev. — 2011. — Vol. 7. — P. 190-200.
Vorob'eva I.V., Gigineishvili D.N. Rol' disfunkcii jendotelija v patogeneze diabeticheskoj retinopatii u bol'nyh saharnym diabetom 2 tipa. Obzor. Oftal'mologija. 2012;9(3):9-13.
American Diabetes Association: Standarts of medical care in diabetes-2011 // Diabetes care. — 2011. — Vol. 34, Suppl. I: S4–88.
Shestakova M. V., Shamhalova M. Sh. Sovremennyj podhod k profilaktike i lecheniju diabeticheskoj retinopatii: rezul'taty issledovanija DIRECT, 2009. Spravochnik poliklinicheskogo vracha. — 2009. — № 1. — S. 3-39.
Delano FA, Chen AY, Wu KI, et al. The autodigestion hypothesis and receptor cleavage in diabetes and hypertension // Drug Discov Today Dis Models. — 2011. — Vol. 8. — P. 37-46.
Wright AD; Dodson PM. Diabetic Retinopathy and Blockade of the Renin Angiotensin System: New Data from the DIRECT Study Programme // Eye. 2010. — Vol. 24. —P. 1-6.
Porta M, Maldari P, Mazzaglia F. New approaches to the treatment of diabetic retinopathy // Diabetes Obes Metab. — 2011. — Vol. 13. — P. 784-790.
Gavrilova N.A., Tishhenko O.E. Vlijanie sulodeksida na funkcional'noe sostojanie jendotelija u bol'nyh saharnym diabetom i diabeticheskoj retinopatiej // Saharnyj diabet. 2011. № 2. S. 66–68.
Astahov Ju.S., Shadrichev F.E., Lisochkina A.B. Diabeticheskaja retinopatija // Oftal'mologija – 2006. Klinicheskie rekomendacii / pod red. L.K. Moshetovoj, A.P. Nesterova, E.A. Egorova. M.: GJeOTAR-Media, 2006. S. 139–163.
Galstjan G.R. Hronicheskie oslozhnenija saharnogo diabeta: jetiopatogenez, klinika, lechenie / G.R. Galstjan // Russkij medicinskij zhurnal. - 2002,- № 27, T. 10. - S. 23-31.
Williamson J.R. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy / J.R Williamson, R.G. Tilton, K. Chang // Diabetes Metabolism reviews. - 1998. -N 4. - P. 339-370.
Poltorak V.V., Bloh K.O., Malashenko A.M. Jeksperimental'noe modelirovanie saharnogo diabeta dlja izuchenija specificheskogo jeffekta novyh antidiabeticheskih veshhestv (Metod. rekomend.). Har'kov, 1991. 20 s.
Pasechnikova N. V. Zashhitnoe dejstvie kvercetina i lipoata na funkcional'nye gruppy belkov setchatki pri modelirovanii diabeta / N.V. Pasechnikova, O.A. Moroz // Oftal'mologіchnij zhurnal. – 2015. – № 3. – S. 76-81
Jeksperimental'naja model' saharnogo diabeta 2-go tipa u krys, vyzvannaja dietoj s vysokim soderzhaniem zhirov i streptozotocinom v nizkoj doze / O.A. Kajdash, V.V. Ivanov, A.I. Vengerovskij, E.E. Bujko, I.A. Shhepetkin // Bjulleten' sibirskoj mediciny. – 2020. – №19(2). – S.41-47.
Rol' metformina v profilaktike diabeticheskoj nefropatii pri jeksperimental'nom saharnom diabete 2 tipa / V.K. Bajrasheva, A.Ju. Babenko, Ju.V. Dmitriev, A.A.Bajramov, S.G. Chefu, I.S. Shatalov, A.N. Aref'eva, I.Ju. Pchelin, N.V. Hudjakova, P.G. Aliev, E.N. Grineva // Regionarnoe krovoobrashhenie i mikrocirkuljacija. – 2016. – №15(3). – S.70-80.
Pokrovskij M.V. Jendotelioprotektornye jeffekty L-arginina pri modelirovanii deficita okisi azota / M.V. Pokrovskij, T.G. Pokrovskaja V.I. Korchakov // Jeksperimental'naja i klinicheskaja farmakologija. – 2008. – № 71 (2). – S. 29–31.
Efficacy of Subconjunctival Aflibercept Versus Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model / Orly Gal-Or 1, Eitan Livny, Ruti Sella, Yael Nisgav, Dov Weinberger, Tami Livnat, Irit Bahar // Cornea. – 2016. – Vol. 3. – Issue 7. – R. 991-996.
Savytskyi. I. V.; Levytskyi, I. M.; Levytska, G. V.; Miastkivska, I. V.; Kuzmenko, I. A. Dynamics of vasoconstriction and vasodilation potential on the background of experimental rhegmatogenous retinal detachment and its correction. Journal of Education, Health and Sport 2016, 6 (2), p. 367-375.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Y. Sirman, I. Savytskyi, N. Preys, O. Blavatska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 272
Number of citations: 0